Table 1.
Summary of included studies. References are reported in the Supplementary Material.
| Author | Year of publication | Country | N of patients | Study design | Selected outcomes |
|---|---|---|---|---|---|
| Aries | 2022 | France (Mayotte Island) | 156 | Single center, retrospective | Mortality, MVT, hospital LOS, ICU LOS, S T, myocarditis, VAP and ECMO implantation |
| Asghar | 2021 | Pakistan | 160 | Single center, retrospective | Mortality, ST, myocarditis and ARF |
| Begum | 2022 | Australia | 2493 | Multicenter, prospective | Mortality, MVT, hospital LOS, ICU LOS, S T, myocarditis, ARF and ECMO implantation |
| Carbonell | 2021 | Spain, Andorra and Ireland | 3795 | Multicenter, retrospective | Mortality, MVT, hospital LOS, ICU LOS, myocarditis, ARF, VAP and ECMO implantation |
| Countou | 2021 | France | 132 | Single center, retrospective | Mortality, MVT, ICU LOS, ST, ARF and VAP |
| Demoule | 2022 | France | 1166 | Multicenter, retrospective | Mortality, MVT, hospital LOS, ICU LOS, ARF, VAP and ECMO implantation |
| Dongelmans | 2022 | Netherlands | 12,218 | Multicenter, prospective | Mortality, MVT, hospital LOS, ICU LOS, S T, myocarditis, VAP and ECMO implantation |
| Haase | 2022 | Denmark | 1374 | Multicenter, retrospective | Mortality, MVT, hospital LOS, ICU LOS, ARF and ECMO implantation |
| Hosoda | 2022 | Japan | 128 | Multicenter, retrospective | Mortality, MVT, ICU LOS, ARF and ECMO implantation |
| Kerai | 2021 | India | 220 | Multicenter, retrospective | Mortality, MVT, ICU LOS and ARF |
| Kieninger | 2022 | Germany | 157 | Single center, retrospective | Mortality, ICU LOS, ARF and ECMO implantation |
| Lalla | 2021 | South Africa | 490 | Single center, prospective | Mortality, MVT, hospital LOS, ICU LOS, S T, myocarditis, VAP and ECMO implantation |
| Lazaro | 2022 | Brazil | 767 | Single center, prospective | Mortality, ICU LOS and ARF |
| Le Terrier | 2022 | Switzerland | 223 | Single center, prospective | Mortality, MVT, hospital LOS, ICU LOS, ST, ARF, VAP and ECMO implantation |
| Lopez | 2021 | France | 111 | Single center, retrospective | Mortality, hospital LOS, ICU LOS, ST, ARF, VAP and ECMO implantation |
| Mayerhofer | 2021 | Austria | 508 | Multicenter, prospective | Mortality, MVT, hospital LOS, ICU LOS, ARF and ECMO implantation |
| Namendis-Silva | 2021 | Mexico | 67,242 | Multicenter, retrospective | Mortality |
| Perez-Acosta | 2022 | Spain (Canary Islands) | 72 | Single center, prospective | Mortality, MVT, hospital LOS, ICU LOS, ST, myocarditis and ARF |
| Piagnerelli | 2021 | Belgium | 174 | Single center, retrospective | Mortality, MVT, hospital LOS, ICU LOS, ST and ARF |
| Ritchie | 2022 | United Kingdom | 330 | Multicenter, retrospective | Mortality and ICU LOS |
| Routsie | 2021 | Greece | 262 | Single center, retrospective | Mortality, MVT, Hospital LOS, ICU LOS and ARF |
| Szakmany | 2021 | United Kingdom | 178 | Single center, retrospective | Mortality and ICU LOS |
| Taxbro | 2021 | Sweden | 264 | Multicenter, retrospective | Mortality, MVT, hospital LOS, ICU LOS, S T, myocarditis, ARF and ECMO implantation |
| Wilcox | 2022 | United Kingdom | 30,035 | Multicenter, retrospective | Mortality and ICU LOS |
| Zirpe | 2021 | India | 3498 | Multicenter, prospective | Mortality |
ARF, acute renal failure; ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; LOS, length of stay; MVT, mechanical ventilation time; ST, systemic thromboembolism; VAP, ventilator associated pneumonia.